Botox Could Soon Treat Lower Limb Spasticity

Article

The FDA has accepted Allergan's resubmission to approve the use of onabotulinumtoxinA (Botox) for lower limb spasticity in adults.

The FDA has accepted Allergan’s resubmission to approve the use of onabotulinumtoxinA (Botox) for lower limb spasticity in adults.

Back in April, the FDA expanded Botox’s label for the treatment of upper limb spasticity, increasing the maximum dose from 360 units to 400 units for this indication. The FDA also increased the maximum Botox cumulative dose within 3 months to 400 units in adults treated for 1 or more indications.

Now, the FDA is expected to act on Allergan’s resubmitted supplemental Biologics License Application (sBLA) to add ankle and toe muscles spasticity to Botox’s label in the first quarter of 2016.

This resubmission contains additional data from a double-blind, placebo-controlled study involving 468 adult patients with lower limb spasticity.

It is not known whether Botox is safe or effective to treat increased stiffness in lower or upper limb muscles other than those in the elbow, wrist, fingers, and thumb.

Some of the common side effects associated with Botox include dry mouth, discomfort, tiredness, and headache. Allergic reactions have been reported in some patients, which may cause itching and wheezing.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.